Glenmark’s NCE GRC 27864 for chronic inflammatory diseases to take part in human trials
GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Optel Vision to invest in pharmaceutical manufacturing industries
To expand distribution resources in Europe, Americas and Asia
Aurobindo completes acquisition of select Western European Businesses of Actavis
Actavis and Aurobindo have also entered into a long-term commercial and supply arrangement
Merck Sorono launches global initiative to improve patient outcomes in metastatic colorectal cancer
The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial…
PARADIGM-HF trial of Novartis’ LCZ696 for chronic heart failure closes early based on strength…
Data Monitoring Committee (DMC) unanimously recommends early closure
US FDA to hold public hearing on clinical trial demographic data
Invites stakeholders for April 1 hearing
Bosch presents training concept of new Bosch Packaging Academy
Offers customers and employees a standardised knowledge pool for the entire machine portfolio from Bosch Packaging Technology
Healthcare private equity investment declines in the US and Europe: GlobalData
Asia-Pacific sees 125.8 per cent increase
Archivel Farma scouts for partners to begin last stage of development of RUTI vaccine against…
Archivel has carried out a restructuring of its team to facilitate the entry of new partners who can carry out the phase III study…
Videojet Technologies to showcase its latest technology breakthroughs at Interpack 2014
Will launch the latest in print and apply labelling (LPA) innovations
Infosys Public Services to set up testing centre of excellence and consolidate IT Services for Prime…
Prime Therapeutics will streamline and optimise its quality assurance and testing services
USFDA advisory committee votes against approval of Novartis’ RLX030
RLX030 is under review to improve the symptoms of AHF through reduction of the rate of worsening of heart failure
Shin-Etsu conducts technical seminars in Bangalore and Hyderabad
First session focused on 'Solid Dispersion' and second session on 'Tableting and CoatingShin-Etsu recently conducted technical…
Conference on ‘Drugs for the Future: Infectious Diseases’ kickstarts at NIPER, Hyderabad
Saw participation from 450 delegatesA conference on 'Drugs for the Future: Infectious Diseases' is being held at National…
StemCyte India Therapeutics to expand its operations in India by opening new collection centres
To build 5,000 plus public inventory of UCB units StemCyte India Therapeutics, a unit of StemCyte USA plans to expand its…
Piramal Enterprises receives GLP compliance certificate from NGCMA
The R&D facility in Goregaon, Mumbai is engaged in drug discovery and development of NCE in the area of oncology and metabolic…
Lupin acquires stake in Laboratorios Grin, Mexico
The acquisition marks Lupin’s foray into the high growth Mexican and the larger Latin American pharmaceuticals market Lupin has…
University of Greifswald in collaboration with Polyclone
To engineer transaminase enzymes in order to broaden the substrate scope